Twist Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Twist Bioscience Corp
TWST Stock  USD 32.39  0.67  2.11%   
Analyzing historical trends in various income statement and balance sheet accounts from Twist Bioscience's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Twist Bioscience's valuation are summarized below:
Gross Profit
191 M
Profit Margin
(0.21)
Market Capitalization
2 B
Enterprise Value Revenue
4.843
Revenue
376.6 M
There are currently one hundred twenty fundamental trend indicators for Twist Bioscience Corp that can be evaluated and compared over time across competition. All traders should double-check Twist Bioscience's current fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

Twist Bioscience Total Revenue

454.71 Million

Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 679.5 K, Net Interest Income of 13.7 M or Interest Income of 13.7 M, as well as many indicators such as Price To Sales Ratio of 4.88, Dividend Yield of 0.0 or PTB Ratio of 2.26. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
  
Build AI portfolio with Twist Stock
Check out the analysis of Twist Bioscience Correlation against competitors.

Twist Bioscience Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets501.6 M738.1 M363.6 M
Slightly volatile
Short and Long Term Debt Total89.7 M68 M118.1 M
Slightly volatile
Other Current Liabilities72 M68.5 M25.1 M
Slightly volatile
Total Current Liabilities54.2 M105.1 M40.9 M
Slightly volatile
Other Liabilities65.5 K69 K433.8 K
Very volatile
Property Plant And Equipment Net105.4 M174.4 M77.1 M
Slightly volatile
Current Deferred Revenue5.7 M6.2 M6.3 M
Very volatile
Accounts Payable9.8 M12.8 M7.3 M
Slightly volatile
Cash200.3 M210.5 M139.7 M
Slightly volatile
Non Current Assets Total373 M355.2 M141.8 M
Slightly volatile
Non Currrent Assets Other5.6 M8.4 M4 M
Slightly volatile
Long Term Debt1.2 M1.3 M5.3 M
Slightly volatile
Cash And Short Term Investments270.1 M267.3 M192.5 M
Slightly volatile
Net Receivables68.9 M65.6 M22.9 M
Slightly volatile
Good Will99.3 M94.5 M33.4 M
Slightly volatile
Common Stock Shares Outstanding44.8 M68.8 M36.2 M
Slightly volatile
Long Term Debt Total1.2 M1.3 M81.7 M
Slightly volatile
Liabilities And Stockholders Equity501.6 M738.1 M363.6 M
Slightly volatile
Non Current Liabilities Total84.1 M69.7 M113.3 M
Slightly volatile
Capital Surpluse2 B1.9 B752.4 M
Slightly volatile
Inventory20.3 M32.6 M14.3 M
Slightly volatile
Other Current Assets18.4 M17.5 M6.8 M
Slightly volatile
Other Stockholder Equity2.2 B2.1 B794.4 M
Slightly volatile
Total Liabilities123.5 M152 M152 M
Pretty Stable
Property Plant And Equipment Gross297.8 M283.7 M104.9 M
Slightly volatile
Short and Long Term Debt1.3 M1.4 M2.2 M
Very volatile
Preferred Stock Total Equity228.9 M334.1 M228.9 M
Slightly volatile
Total Current Assets326.1 M382.9 M233.5 M
Slightly volatile
Non Current Liabilities Other816.1 K859 K5.2 M
Pretty Stable
Short Term Debt10.2 M15.9 M7.4 M
Slightly volatile
Intangible Assets18 M15.4 M11.9 M
Slightly volatile
Property Plant Equipment258.9 M246.5 M92.3 M
Slightly volatile
Net Working Capital296 M277.8 M196.8 M
Slightly volatile
Deferred Long Term Liabilities3 M3.3 M3.6 M
Slightly volatile
Capital Lease Obligations81.1 M86.9 M52.4 M
Slightly volatile
Long Term Investments65.6 M62.5 M12 M
Slightly volatile

Twist Bioscience Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income13.7 M13.1 M4.6 M
Slightly volatile
Depreciation And Amortization30 M28.6 M12.1 M
Slightly volatile
Interest Expense24.8 K26.1 K549.2 K
Slightly volatile
Selling General Administrative138.2 M276 M103.6 M
Slightly volatile
Selling And Marketing Expenses8.5 M8.1 M2.5 M
Slightly volatile
Total Revenue454.7 M433.1 M138.4 M
Slightly volatile
Other Operating Expenses313.6 M589.8 M234.4 M
Slightly volatile
Research Development66.4 M92.3 M50.2 M
Slightly volatile
Cost Of Revenue224.1 M213.4 M81.2 M
Slightly volatile
Total Operating Expenses215.2 M376.4 M160.6 M
Slightly volatile
Reconciled Depreciation16.5 M28.6 M12.4 M
Slightly volatile
Non Recurring18 M20.2 M22.1 M
Slightly volatile

Twist Bioscience Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation77.8 M74.1 M26.6 M
Slightly volatile
Begin Period Cash Flow184.5 M260.3 M133.9 M
Slightly volatile
Other Cashflows From Financing Activities12.8 M13.5 M59.3 M
Slightly volatile
Depreciation15.4 M28.6 M12 M
Slightly volatile
Capital Expenditures25.4 M32.2 M18.8 M
Slightly volatile
Total Cash From Financing Activities24.4 M25.7 M101.1 M
Very volatile
End Period Cash Flow201.4 M210.5 M140.4 M
Slightly volatile
Change To Netincome99.4 M94.7 M35.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.885.1450.3147
Slightly volatile
Days Sales Outstanding84.7463.5688.2506
Slightly volatile
Stock Based Compensation To Revenue0.240.190.2649
Slightly volatile
Capex To Depreciation1.481.011.6681
Very volatile
EV To Sales4.574.8146.8527
Slightly volatile
Inventory Turnover6.837.546.7522
Slightly volatile
Days Of Inventory On Hand57.3850.1162.509
Slightly volatile
Payables Turnover14.6915.0513.7376
Slightly volatile
Sales General And Administrative To Revenue0.70.733.4754
Slightly volatile
Research And Ddevelopement To Revenue0.230.253.2031
Slightly volatile
Capex To Revenue0.08120.08551.0991
Slightly volatile
Cash Per Share4.453.54.6135
Slightly volatile
Days Payables Outstanding23.8425.0959.5152
Slightly volatile
Income Quality0.810.710.7838
Slightly volatile
Intangibles To Total Assets0.140.130.0708
Slightly volatile
Net Debt To EBITDA1.951.860.9967
Slightly volatile
Current Ratio6.964.196.3777
Slightly volatile
Receivables Turnover4.15.944.53
Slightly volatile
Capex Per Share0.410.420.4467
Pretty Stable
Revenue Per Share5.955.672.3926
Slightly volatile
Interest Debt Per Share0.821.140.9086
Slightly volatile
Debt To Assets0.080.110.115
Slightly volatile
Operating Cycle164128153
Pretty Stable
Days Of Payables Outstanding23.8425.0959.5152
Slightly volatile
Ebt Per Ebit1.030.650.9508
Slightly volatile
Quick Ratio6.63.836.1016
Slightly volatile
Net Income Per E B T1.11.161.0154
Slightly volatile
Cash Ratio3.932.33.4385
Very volatile
Cash Conversion Cycle78.2180.2188.395
Slightly volatile
Days Of Inventory Outstanding57.3850.1162.509
Slightly volatile
Days Of Sales Outstanding84.7463.5688.2506
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.01.431.2201
Slightly volatile
Fixed Asset Turnover1.192.231.1236
Slightly volatile
Debt Ratio0.080.110.115
Slightly volatile
Price Sales Ratio4.885.1450.3147
Slightly volatile
Asset Turnover0.550.530.2313
Slightly volatile

Twist Bioscience Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap524.6 M590.2 M644.2 M
Slightly volatile
Enterprise Value493.4 M555.1 M605.9 M
Slightly volatile

Twist Fundamental Market Drivers

Twist Upcoming Events

2nd of February 2024
Upcoming Quarterly Report
View
3rd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About Twist Bioscience Financial Statements

Twist Bioscience shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may analyze each financial statement separately, they are all interrelated. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Twist Bioscience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue6.2 M5.7 M
Total Revenue433.1 M454.7 M
Cost Of Revenue213.4 M224.1 M
Stock Based Compensation To Revenue 0.19  0.24 
Sales General And Administrative To Revenue 0.73  0.70 
Research And Ddevelopement To Revenue 0.25  0.23 
Capex To Revenue 0.09  0.08 
Revenue Per Share 5.67  5.95 
Ebit Per Revenue(0.33)(0.34)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY